Request Demo
Last update 29 Aug 2025
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Last update 29 Aug 2025
Overview
Tags
Hemic and Lymphatic Diseases
Other Diseases
Congenital Disorders
Non-recombinant coagulation factor
Immunoglobulin
Blood components
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20242489
评价静注人免疫球蛋白（10%）在成人及青少年中治疗原发免疫性血小板减少症（ITP）有效性和安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of intravenous human immunoglobulin (10%) in the treatment of primary immune thrombocytopenia (ITP) in adults and adolescents
CTR20240019
单臂、开放性、多中心临床试验评价人凝血因子Ⅸ治疗中重型血友病B的有效性、安全性以及药代动力学研究
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy, safety, and pharmacokinetics of human coagulation factor IX in the treatment of moderate to severe hemophilia B
CTR20222719
评价人纤维蛋白粘合剂对骨伤微创手术切口止血的有效性和安全性的随机、开放、平行对照探索性临床试验
[Translation] A randomized, open, parallel controlled exploratory clinical trial to evaluate the effectiveness and safety of human fibrin adhesive in hemostasis of minimally invasive surgery for bone injuries
100 Clinical Results associated with Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 19 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
2
1
NDA/BLA
Approved
2
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free